Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of CAP Guideline

Mismatch Repair and Microsatellite Instabilit...

Up next

Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2026.3.1 Part 2

Dr. Joshua Reuss returns to the podcast to discuss the update to the living guideline on stage IV NSCLC with driver alterations. The conversation focuses on new cancer treatment strategies for patients with advanced NSCLC and EGFR mutations, including classical EGFR alterations ( ...  Show more

Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2026.3.1 Part 1

Dr. Lyudmila Bazhenova joins the podcast to share the update to the living guideline on stage IV NSCLC without driver alterations. Dr. Bazhenova discusses the evidence reviewed for both non-squamous NSCLC, including the POD1IM-304 and BAP BRAIN trials, and squamous cell NSCLC, in ...  Show more

Recommended Episodes

A Revolution in Immunotherapy for Cervical and Endometrial Cancers
ASCO Daily News

<span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;">Doctors James Ferriss, Linda Duska, and Jayanthi Lea discuss the promise and the challenges of targeting the immune system with immune checkpoin ...

  Show more

Optimizing Novel Therapies and Surgery in Early-Stage NSCLC
ASCO Daily News

Doctors Vamsi Velcheti, Sandip Patel, and Michael Zervos discuss recent updates on the management of early-stage non-small cell lung cancer (NSCLC), including the optimization of neoadjuvant and adjuvant treatment options for patients and the role of surgery in the era of targ ...

  Show more

Advances in Precision Oncology for GI Cancers at GI24
ASCO Daily News

<span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;">Drs. Shaalan Beg and Rachna Shroff discuss key abstracts on GI cancers that were featured at the 2024 ASCO Gastrointestinal Cancers Symposium, including SKYSCRAPER-08, EMERALD-1, and N ...

  Show more

ASCO24: The Future of Personalized Immunotherapy
ASCO Daily News

<span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;"><span class="normaltextrun"> <span style= "line-height: 107%; color: black; background: white;">Dr. Diwakar Davar and Dr. Jason Luke discuss key abstracts from the 2024 ASCO Annual Meeting that explore ...

  Show more